Clinical pharmaceutical care for one case with diabetic nephropathy and renal tubular interstitial lesions
CHANG Xin-yu1, TANG Kun2*, GUO Gui-ming1
1. Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China; 2. Department of Pharmacy, Beijing Chinese Medicine Hospital Affiliated to Capital Medical University, Beijing 100038, China
Abstract：Objective: To explore the role of clinical of pharmacists in the treatment of the patient with diabetic nephropathy. Methods: Through participating in the treatment of a patient with diabetic nephropathy, clinical pharmacists assisted doctors to adjust medication protocol. Results: The pharmaceutical care provided by clinical pharmacists contributed to enhancement of patient compliance to treatment and improvement of the drug treatment level. Conclusion: Clinical pharmacy service can provide effective help in rational drug use.
[1] KDOQI．KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease[J]．Am J Kidney Dis, 2007, 49(Suppl 2)：S12-154．
[2] 中华医学会糖尿病学分会微血管并发症学组. 糖尿病肾病防治专家共识（2014 年版）[J]. 中华糖尿病杂志, 2014, 6(11):792- 801.
[3] Marbury T C, Ruckle J L, Hatorp V, et a1．Pharmacokinetics of repaglinide in subjects with renal impairment[J]．clin Phamacol Ther, 2000(67):7-15．
[4] Hsu T W, Liu J S, Hung S C, et al. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia[J]. JAMA Intern Med, 2014 ,174(3):347-354.
[5] Mann J F, Schmieder R E, Mc Queen M, et a1. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial[J]. Lancet, 2008, 372(9638):547-553.
[6] Palmer S C, Mavridis D, Navarese E, et a1．Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis [J]. Lancet, 2015, 385(9982):2047-2056.
[7] 刘红, 孙伟, 顾刘宝, 等. 黄葵胶囊联合ACEI 或ARB 类药物治疗糖尿病肾病的Meta 分析[J]. 中华中医药杂志, 2015, 30(5):1712-1718.
[8] 苏清敏, 孟红梅, 张秋芬, 等. 黄葵胶囊对糖尿病肾病患者血管内皮功能的影响[J]. 临床合理用药, 2015, 8(3):63-64.
[9] 王宝福, 谢席胜, 冯胜刚, 等. 舒洛地特治疗糖尿病肾病的系统评价[J]. 中国中西医结合肾病杂志, 2013, 14(6):524-529.
[10] Satirapoj B, Kaewput W, Supasyndh O, et a1. Effect of sulodexide on urinary biomarkers of kidney injury in normoalbuminuric type 2 diabetes: a randomized controlled trial. [J].J Diabetes Res, 2015:172038. doi: 10.1155/2015/172038.
2016, Vol. 14 
